Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Cordis has received U.S. Food and Drug Administration (FDA) approval for its new MYNX Control Venous Vascular Closure Device (VCD) for 6F-12F access sites. The company hopes to launch the newly approved extravascular closure device in the months ahead.

Cordis gains FDA approval for new closure device, inks pricing deal with Premier

The newly approved extravascular closure device was designed for procedures with access sites from 6 to 12 French. It uses the same proprietary GRIP technology found in other Cordis interventional devices.

MRI study shows how magic mushrooms affect brain connectivity in a way that allows people to temporarily escape reality

MRIs pinpoint how magic mushrooms affect brain connectivity, paving way for effective mental health therapeutics

A new MRI analysis shows how psilocybin temporarily alters the signals of the brain’s default mode network.

StreamlineValve self-cleaning TAVR valve inspired by nature

Self-cleaning TAVR valve offers potential of fewer clots, better outcomes

Inspired by nature and funded by the European Research Council, a group of scientists and engineers thinks its new research could represent a significant breakthrough in TAVR care.

A TAVR procedure being performed at Northwestern Medicine in Chicago. These structural heart procedures require a team approach.

Temporary pacemakers after TAVR could reduce need for permanent implants

Care teams are always looking for new ways to limit the use of permanent pacemakers after TAVR. Could starting patients off with temporary devices be an answer? 

heart doctors and surgeons working together. top cardiology hospitals in the United States.

The 25 best heart hospitals in the United States

U.S. News & World Report is back with its latest rankings. Did your facility make the cut? 

Innovalve Bio Medical's Innostay TMVR device. Edwards Lifesciences has agreed to acquire Innovalve after an initial investment in 2017.

Edwards Lifesciences to acquire medical device startup behind new TMVR technology

Edwards, an early investor when the company first launched in 2017, said the acquisition will ensure its TMVR platform reaches as many patients as possible. 

Video interview with Jim Melton, DO, vascular surgeon, explains the CLI mortality rate among amputees in rural Oklahoma, and the need for outreach programs to screen more patients.

Death rate from critical limb ischemia is high in rural Oklahoma

In rural Oklahoma, double amputees due to untreated peripheral artery disease face mortality rates around 35% after one year and 60% after two. Jim Melton, DO, hopes his mobile cardiology clinics can make a difference for these patients.

Thumbnail

Could focused ultrasound help rewire the brain to be more present? Research suggests it's a possibility

Experts say new study results are "a really powerful thing for the whole field of neuroscience."